Showing 1801-1810 of 3437 results for "".
DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-latest-on-galderma-eczema-awareness-hacking-derm-and-more/19675/In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses herEstablishing Incentives for Practice Administrators
https://practicaldermatology.com/topics/practice-management/establishing-incentives-for-practice-administrators/23051/Tips to create a performance-based program that compensates appropriately and motivates the administrator to continue moving the practice forward.Galderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abd-eyes-mohs-certification-sun-s-ilumya-approved-fue-update/18319/The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialty certificate in Micrographic Dermatologic Surgery. Dermatologists react. Ilumya or tildrakizumab from Sun Pharma is approved for moderate to severe psoriasis. Medicine the MusicalNew Advancements in Microneedle Resurfacing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-advancements-in-microneedle-resurfacing/21354/Microneedle resurfacing has quickly become one of the most in-demand aesthetic procedures, likely due to its strong results, quick healing times, and cost-effectiveness.Laser Scar Revision
https://practicaldermatology.com/issues/supplements/laser-scar-revision/21463/Experts discuss reimbursement issues, treatment protocols, combination therapy, as well as the future for scar revision therapy.Innovations in Oncology Learning Center: From Guidelines to Practice: Melanoma
https://practicaldermatology.com/programs/cme/innovations-in-oncology-learning-center-from-guidelines-to-practice-melanoma/33212/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Taking the Pulse of Hydroquinone Therapy: A Plea for Caution
https://practicaldermatology.com/topics/general-topics/taking-the-pulse-of-hydroquinone-therapy-a-plea-for-caution/22946/Pulse therapy under physician supervision can reduce long-term exposure and help reduce the risk of untoward effects of hydroquinone therapy.Lichen Amyloidosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/lichen-amyloidosis/20681/A Rational Criteria: When Not to Treat Warts
https://practicaldermatology.com/topics/infections-infectious-disease/a-rational-criteria-when-not-to-treat-warts/23813/How to decide which warts to let resolve on their own.